Kyle Faget and Jami Gekas Author Article on Gender-Affirming Care Regulations
November 12, 2025
Journal of Health Care Compliance
Foley & Lardner LLP partner Kyle Faget and Jami Gekas authored the article “Federal Trade Commission Workshop Addresses Healthcare Provider Deceptive Trade Practices in Provision of Gender-Affirming Care (GAC),” for the November – December 2025 issue of Journal of Health Care Compliance.
Faget and Gekas examine how health care providers, clinics, and drug manufacturers could face civil, criminal, and regulatory actions under expansive consumer protection interpretations for their role in offering or promoting GAC to minors.
“Although the Federal Trade Commission is soliciting feedback on this issue, stakeholders in the health care space should be aware of potential enforcement actions and class actions in the future,” the authors conclude.
People
Related News
October 9, 2026
In the News
Jonathan Lasken Highlighted Across the Media for Arrival to Foley
Foley & Lardner LLP partner Jonathan Lasken is highlighted across the media for his recent arrival to the firm’s Washington D.C. office.
October 7, 2026
In the News
William Holtz Examines New FDA Approach to Clinical Trial Development
Foley & Lardner LLP of counsel William Holtz is quoted in the PharmaVoice article, “5 Key Facts About the FDA Expedited IND Pilot Program,” examining the FDA's new pilot program and its potential to accelerate clinical research.
October 5, 2026
In the News
Louis Lehot Analyzes U.S. IPO Market Trends and Outlook
Foley & Lardner LLP partner Louis Lehot is featured in the Daily Journal‘s Capital & Counsel newsletter offering insights on the current state of the U.S. IPO market and the factors influencing companies' routes to going public.